Stocks
Featured
More In Stocks
US Stock Sector Outlooks: Morningstar’s Top Q3 Picks Across the Market
Morningstar analysts provide their sector outlooks and views on the best stocks to buy.
ASML Earnings: Long-Term Prospects Vastly Improved
While the new 2026 outlook is no big surprise, we raise our fair value estimate.
Rio Tinto: Solid Second Quarter and First Half of 2026
We maintain our fair value estimate for Rio Tinto stock.
JPMorgan Chase Earnings: Easily Hurdles Sky-High Expectations
We’ve raised our fair value estimate for JPMorgan stock.
AI Is Globalizing Many of the World’s Stock Markets. Here’s What That Means for Investors
Morningstar Indexes’ global revenue study shows many equity markets have become more internationally connected, led by the rise of AI companies.
Mining Stocks: Mineral Resources Is the Best Value as We Update Our Assumed Prices
Our update on select stocks from the mining sector.
Vodafone: Xavier Niel Is the Catalyst We’ve Looked For, Fair Value Estimate Raised
We think Vodafone Group stock is moderately undervalued.
SK Hynix: ADRs Begin Trading Under New Ticker
We think SK Hynix stock is fairly valued.
Private Capital Is Taking AI Chips Off the Table
This week’s Csquare IPO fits a pattern of AI asset sales by private capital giants.
Q3 US Stock Market Outlook: Investors Face Balanced Risks, Selective Opportunities
What to know about positioning for the second half of 2026, and where we see opportunity by sector.
Going Into Earnings, Is Netflix Stock a Buy, a Sell, or Fairly Valued?
With fierce competition in the streaming industry, we’re watching how Netflix’s sales and customer base evolves.
Is Now a Good Time to Buy European Stocks?
Following a strong start to the summer, the European equity market is now more expensive than the American one.
What Happens if OpenAI Delays Its IPO to 2027?
Three possible scenarios if one of this year’s most hotly anticipated IPOs is pushed back.
EasyJet Shares Jump as Surprise Apollo Bid Raises Odds of Bidding War
Apollo topping Castlelake’s offer may only be the opening round of bidding, analysts say.
Why Wayve’s Record Pisces Trade Could Mean Fewer IPOs, Not More
The UK’s private stock market was pitched as a stepping stone to going public. Its biggest trade yet may be doing the opposite.
Ionis and AstraZeneca: Shares Tank as Phase 3 ATTR-CM Trial Falls Short of Expectations
We lower our fair value estimate for Ionis Pharmaceuticals.
Forget SpaceX—SK Hynix’s Record US IPO Tests the AI Trade’s Hottest Corner
The giant South Korean chipmaker is looking to raise $28 billion from US investors just as memory stocks are tumbling after massive gains.
GSK: Is This FTSE 100 Pharma Stock Making a Comeback?
Analysts weigh in after new CEO Luke Miels marked his first six months in charge with the $10.6 billion acquisition of Nuvalent.
Alibaba: State-Led Data Center Could Reduce Cloud Revenue
We’ve reduced our fair value estimate of Alibaba stock.
Apple: Renewed Broadcom Agreement Adds AI Cherry on Top
We maintain fair value estimates for Apple and Broadcom.
